Department of Urology, Renmin Hospital, Hubei University of Medicine, Shiyan, Hubei, 442000, PR China.
School of Basic Medical Sciences, Ningxia Medical University, Yinchuan, Ningxia, 750004, China.
World J Urol. 2024 Nov 28;42(1):653. doi: 10.1007/s00345-024-05364-9.
The cardiometabolic index (CMI), encompassing obesity and lipid metrics, is potentially linked to kidney stone prevalence in diabetic patients. However, studies on this association are sparse. This research evaluates CMI's impact on kidney stone occurrence in this group.
Utilizing data from the 2007-2018 National Health and Nutrition Examination Survey, we explored the relationship between CMI and kidney stones in diabetic patients through multivariate logistic regression, generalized additive models, and smoothed curve fitting. Robustness checks included subgroup analyses and propensity score matching (PSM).
This study comprised 2714 participants in total, where the prevalence of kidney stones was found to be 16.82%. Using weighted multivariate logistic regression and fully adjusted models, it was revealed that elevated CMI levels are positively associated with an increased likelihood of developing kidney stones (OR = 1.17, 95% CI: 1.06, 1.30). Smooth curve fitting demonstrated that there was no non-linear relationship between CMI and kidney stones (log-likelihood ratio test P = 0.236). Subgroup analyses and interactions indicated that the association between CMI and kidney stone prevalence was notably stronger in individuals who were living with a partner /married and had a poverty income ratio (PIR) of 1.5 to less than 3.5 (P for interaction < 0.05). propensity score matching (PSM) further verified the robustness of our results.
Elevated CMI correlates with greater kidney stone prevalence in diabetic individuals, particularly those married or living with a partner and within certain economic statuses. This study supports the hypothesis linking CMI and kidney stones in U.S. diabetic population, suggesting a target demographic for preventive strategies.
心脏代谢指数(CMI)涵盖肥胖和脂质指标,与糖尿病患者肾结石的患病率可能相关。然而,关于这种关联的研究很少。本研究评估了 CMI 对这一人群肾结石发生的影响。
利用 2007-2018 年全国健康和营养调查的数据,我们通过多变量逻辑回归、广义加性模型和平滑曲线拟合,探讨了 CMI 与糖尿病患者肾结石之间的关系。稳健性检验包括亚组分析和倾向评分匹配(PSM)。
本研究共纳入 2714 名参与者,肾结石的患病率为 16.82%。使用加权多变量逻辑回归和完全调整模型,结果显示,CMI 水平升高与肾结石发生的可能性增加呈正相关(OR=1.17,95%CI:1.06,1.30)。平滑曲线拟合表明,CMI 与肾结石之间没有非线性关系(对数似然比检验 P=0.236)。亚组分析和交互作用表明,CMI 与肾结石患病率之间的关联在与伴侣同居/已婚且贫困收入比(PIR)为 1.5 至小于 3.5 的个体中更为显著(交互作用 P<0.05)。倾向评分匹配(PSM)进一步验证了我们结果的稳健性。
CMI 升高与糖尿病患者肾结石的患病率增加相关,尤其是已婚或与伴侣同居且处于特定经济状况的患者。本研究支持 CMI 与美国糖尿病患者肾结石之间存在关联的假设,提示了预防策略的目标人群。